NACDS has been instrumental in consistently helping medication therapy management (MTM) services evolve, expand and better target beneficiaries over time. There is now a new opportunity to further advance MTM, which was recently announced by the Centers for Medicare & Medicaid Services’ (CMS) Center for Medicare and Medicaid Innovation (CMMI).
The pilot program presents an opportunity to create better alignment of program incentives for Part D prescription drug plans (PDPs), prescribers, pharmacies and CMS…
The pilot—the Enhanced MTM Demonstration—would allow Part D plans to utilize new and innovative approaches to MTM, such as more efficient outreach and targeting strategies, and tailoring the level of services to the beneficiary’s needs. The pilot program presents an opportunity to create better alignment of program incentives for Part D prescription drug plans (PDPs), prescribers, pharmacies and CMS, and has the potential to improve access to MTM services and medication adherence.
The pilot also creates opportunities for pharmacies who would like to participate. Standalone prescription drug plans in 11 states can participate in the pilot, so interested NACDS members need to approach plans with proposals for target populations and intervention approaches. Interested companies will need to act fast, however, because the timeline for plans to submit applications and launch the demonstration are very tight. Plans will need to submit applications by January 8, 2016.
NACDS is working with House and Senate MTM supporters to send letters to the Department of Health and Human Services (HHS) in support of the pilot, and is encouraging CMMI to take steps to ensure that retail community pharmacists are included. Once the programs are implemented, NACDS will continue to communicate with the agency to ensure that there are opportunities for pharmacies to participate.